Daihan Pharmaceutical (Korea) Today
| 023910 Stock | KRW 27,250 600.00 2.25% |
Performance4 of 100
| Odds Of DistressLess than 9
|
Daihan Pharmaceutical is trading at 27250.00 as of the 29th of November 2024, a 2.25 percent increase since the beginning of the trading day. The stock's open price was 26650.0. Daihan Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Daihan Pharmaceutical CoLtd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 6 M outstanding shares. More on Daihan Pharmaceutical CoLtd
Moving together with Daihan Stock
Moving against Daihan Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Daihan Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Daihan Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Daihan Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Yun Lee |
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
Daihan Pharmaceutical CoLtd (023910) is traded on KOSDAQ in Korea and employs 7 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 182.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Daihan Pharmaceutical's market, we take the total number of its shares issued and multiply it by Daihan Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Daihan Pharmaceutical operates under Healthcare sector and is part of Pharmaceuticals industry. The entity has 6 M outstanding shares.
Daihan Pharmaceutical CoLtd has accumulated about 83.73 B in cash with 40.62 B of positive cash flow from operations.
Check Daihan Pharmaceutical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Daihan Pharmaceutical is W182.1 Billion. Daihan Pharmaceutical CoLtd retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Daihan Ownership Details
Daihan Pharmaceutical Risk Profiles
Although Daihan Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Daihan Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.6573 | |||
| Semi Deviation | 0.8495 | |||
| Standard Deviation | 1.01 | |||
| Variance | 1.02 |
Daihan Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Daihan Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Other Information on Investing in Daihan Stock
Daihan Pharmaceutical financial ratios help investors to determine whether Daihan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daihan with respect to the benefits of owning Daihan Pharmaceutical security.